Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    8592548 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil
2 Active, not recruiting 18-Month Study of Curcumin
Conditions: Age-associated Cognitive Impairment;   Mild Cognitive Impairment (MCI)
Interventions: Drug: Curcumin;   Other: Placebo
3 Completed Ketasyn in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Ketasyn™ (AC-1202)

Indicates status has not been verified in more than two years